PE/Cyanine7 Anti-Mouse CD19 Antibody[1D3]

PE/Cyanine7 Anti-Mouse CD19 Antibody[1D3]

Introducing the PE/Cyanine7 Anti-Mouse CD19 Antibody [1D3], a highly advanced and meticulously engineered product designed to revolutionize the field of immunology research. This antibody, meticulously developed using cutting-edge technology, offers unparalleled specificity and sensitivity in detecting and analyzing CD19 expression in mouse samples.

The PE/Cyanine7 Anti-Mouse CD19 Antibody [1D3] boasts exceptional performance characteristics, making it an indispensable tool for scientists and researchers alike. With its remarkable affinity for CD19, this antibody enables precise identification and quantification of CD19-positive cells, facilitating comprehensive investigations into the role of CD19 in various biological processes.

Crafted with utmost precision, this antibody exhibits exceptional stability and reproducibility, ensuring consistent and reliable results across experiments. Its unique formulation guarantees minimal background noise, allowing for accurate and precise analysis of CD19 expression levels in complex biological samples.

The PE/Cyanine7 Anti-Mouse CD19 Antibody [1D3] is compatible with a wide range of applications, including flow cytometry, immunofluorescence, and immunohistochemistry. Its versatility enables researchers to explore CD19 expression in diverse experimental settings, providing valuable insights into the mechanisms underlying immune responses and diseases.

Furthermore, this antibody is manufactured in strict adherence to the highest quality standards, ensuring optimal performance and reliability. Rigorous quality control measures are implemented throughout the production process, guaranteeing batch-to-batch consistency and reproducibility.

In summary, the PE/Cyanine7 Anti-Mouse CD19 Antibody [1D3] represents a breakthrough in immunology research, offering exceptional specificity, sensitivity, and versatility. With its unrivaled performance characteristics and stringent quality control, this antibody is poised to revolutionize the study of CD19 and contribute to advancements in our understanding of immune-related processes and diseases.